WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST) from its SEC filings: 2025 revenue $3.1 billion (+6% vs the year before), net margin 16%, free cash flow $468.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $3.1 billion |
| Revenue growth | +6% |
| Net income | $493.7 million |
| Net margin | 16.1% |
| Free cash flow | $468.9 million |
| Diluted EPS | $6.79 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +14% |
| Cash | $435.8 million |
| Long-term debt | $202.9 million |
| Share count, 1 year | -2% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.